Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Expert Opinion on Emerging Drugs
|
July 3, 2007
Fixed-combination and emerging glaucoma therapies
David F Woodward, June Chen
Current Opinion in Drug Discovery & Development
|
July 31, 2007
A historical perspective and recent advances in prostamide research and therapeutics
Robert M Burk, David F Woodward
Trends in Pharmacological Sciences
|
May 4, 2004
The inflow and outflow of anti-glaucoma drugs
David F Woodward, Daniel W Gil
Survey of Ophthalmology
|
March 16, 2004
Update on the mechanism of action of bimatoprost: a review and discussion of new evidence
Achim H-P Krauss, David F Woodward
Expert Review of Ophthalmology
|
September 28, 2011
Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility
Zhou Wan, David F Woodward, W Daniel Stamer
Experimental Eye Research
|
July 26, 2002
Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels
Clayton S Spada, Amelia L Nieves, David F Woodward
Journal of Lipid Research
|
June 3, 2015
Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea
Paula Urquhart, Jenny Wang, David F Woodward, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2016
Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies
David F Woodward, Neil J Poloso, Jenny W Wang
Investigative Ophthalmology & Visual Science
|
January 20, 2011
The role of the prostaglandin EP4 receptor in the regulation of human outflow facility
Lindsay H Millard, David F Woodward, W Daniel Stamer
Investigative Ophthalmology & Visual Science
|
June 15, 2013
Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow
Jenny W Wang, David F Woodward, W Daniel Stamer
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Expert Opinion on Emerging Drugs
|
July 3, 2007
Fixed-combination and emerging glaucoma therapies
David F Woodward, June Chen
Current Opinion in Drug Discovery & Development
|
July 31, 2007
A historical perspective and recent advances in prostamide research and therapeutics
Robert M Burk, David F Woodward
Trends in Pharmacological Sciences
|
May 4, 2004
The inflow and outflow of anti-glaucoma drugs
David F Woodward, Daniel W Gil
Survey of Ophthalmology
|
March 16, 2004
Update on the mechanism of action of bimatoprost: a review and discussion of new evidence
Achim H-P Krauss, David F Woodward
Expert Review of Ophthalmology
|
September 28, 2011
Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility
Zhou Wan, David F Woodward, W Daniel Stamer
Experimental Eye Research
|
July 26, 2002
Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels
Clayton S Spada, Amelia L Nieves, David F Woodward
Journal of Lipid Research
|
June 3, 2015
Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea
Paula Urquhart, Jenny Wang, David F Woodward, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2016
Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies
David F Woodward, Neil J Poloso, Jenny W Wang
Investigative Ophthalmology & Visual Science
|
January 20, 2011
The role of the prostaglandin EP4 receptor in the regulation of human outflow facility
Lindsay H Millard, David F Woodward, W Daniel Stamer
Investigative Ophthalmology & Visual Science
|
June 15, 2013
Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow
Jenny W Wang, David F Woodward, W Daniel Stamer
Page
of 6